These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 221418
1. Effect of ara-T on the replication of herpes simplex virus, varicella-zoster virus and cytomegalovirus. Miller RL, Iltis JP, Rapp F. IARC Sci Publ (1971); 1978; (24 Pt 2):991-7. PubMed ID: 221418 [Abstract] [Full Text] [Related]
2. Differential effect of arabinofuranosylthymine of the replication of human herpesviruses. Miller RL, Iltis JP, Rapp F. J Virol; 1977 Sep; 23(3):679-84. PubMed ID: 197264 [Abstract] [Full Text] [Related]
3. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis. Gephart JF, Lerner AM. Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244 [Abstract] [Full Text] [Related]
4. The effect of 1-beta-D-arabinofuranosylthymine on the growth of herpes simplex virus types 1 and 2. Falke D, Moser H, Link D, Müller WE. J Gen Virol; 1979 Feb; 42(2):435-8. PubMed ID: 217968 [Abstract] [Full Text] [Related]
5. Effect of 5-iodo-5'-amino-2',5'-dideoxyuridine on varicella-zoster virus in vitro. Iltis JP, Lin TS, Prusoff WH, Rapp F. Antimicrob Agents Chemother; 1979 Jul; 16(1):92-7. PubMed ID: 224809 [Abstract] [Full Text] [Related]
6. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. Chono K, Katsumata K, Kontani T, Kobayashi M, Sudo K, Yokota T, Konno K, Shimizu Y, Suzuki H. J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624 [Abstract] [Full Text] [Related]
8. Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro. Aswell JF, Allen GP, Jamieson AT, Campbell DE, Gentry GA. Antimicrob Agents Chemother; 1977 Aug; 12(2):243-54. PubMed ID: 197886 [Abstract] [Full Text] [Related]
9. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination. Champney KJ, Lauter CB, Bailey EJ, Lerner AM. J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024 [Abstract] [Full Text] [Related]
10. Arabinose furanosyl thymidine: uptake, phosphorylation and incorporation into DNA of mammalian cells. Dahmen N, Kowalzick L, Spadari S, Koch G. In Vivo; 1990 Dec; 4(1):25-32. PubMed ID: 1966522 [Abstract] [Full Text] [Related]
11. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico. Conde-Glez C, Lazcano-Ponce E, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E. Vaccine; 2013 Oct 17; 31(44):5067-74. PubMed ID: 24021305 [Abstract] [Full Text] [Related]
12. A proposed mechanism for the selective inhibition of human cytomegalovirus replication by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-fluorouracil. Suzuki S, Misra HK, Wiebe LI, Knaus EE, Tyrrell DL. Mol Pharmacol; 1987 Mar 17; 31(3):301-6. PubMed ID: 3031445 [Abstract] [Full Text] [Related]
16. Comparison of the in vitro and in vivo anti-herpes activities of 1-beta-D-arabinofuranosylthymine and its 5'-monophosphate. Machida H, Sakata S, Morozumi M, Kiyanagi T, Kuninaka A, Yoshino H. Antiviral Res; 1982 Sep 17; 2(4):217-26. PubMed ID: 6293376 [Abstract] [Full Text] [Related]